SCHEMBL15973169

SCHEMBL15973169

CN1CC(=O)N(CC(=O)c2ccccc2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
PLA2G7 Q13093 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 1/20 0.53
GSK3A P49840 2/20 0.52
GSK3B P49841 2/20 0.52
HDAC6 Q9UBN7 1/20 0.49
RECQL P46063 1/20 0.48
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
GFER P55789 1/20 0.45
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7295009 0.79 SMN1; SMN2 (0.54) ALDH1A1KMT2AMEN1PLA2G7SMN1; SMN2
SCHEMBL18825267 0.78 SMN1; SMN2 (0.81) ALDH1A1KMT2AMEN1SMN1; SMN2RAB9A
SCHEMBL13629851 0.75 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1PLA2G7SMN1; SMN2
SCHEMBL11650145 0.75 HDAC6 (0.60) ALDH1A1KMT2AMEN1PLA2G7GSK3A
SCHEMBL1201084 0.74 ALDH1A1 (0.59) ALDH1A1KMT2AMEN1PLA2G7HDAC6
Acetophenone SCHEMBL27775215 0.73 NPC1 (0.47) ALDH1A1KMT2AMEN1PLA2G7SMN1; SMN2
SCHEMBL27746621 0.73 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1PLA2G7HDAC6
SCHEMBL15565060 0.72 ALDH1A1 (0.47) ALDH1A1KMT2ASMN1; SMN2RAB9AGSK3A
SCHEMBL5846697 0.72 SMN1; SMN2 (0.77) ALDH1A1KMT2ASMN1; SMN2RAB9AGSK3A
SCHEMBL10938820 0.72 HDAC6 (0.72) ALDH1A1KMT2AMEN1PLA2G7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2015-12-31 US disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885KMT2A 2891/4885MEN1 649/4885
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885KMT2A 2891/4885MEN1 649/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885KMT2A 2891/4885MEN1 649/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885KMT2A 2891/4885MEN1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.